Analytical Development Intern (Graduate-Level) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 23 hours ago

Analytical Development Intern (Graduate-Level)

Alexion Pharmaceuticals, Inc. is seeking Master's and Doctoral students for a 12-week internship role in Analytical Development. The role involves leading and executing comparability studies, performing protein characterization, and developing analytical methods for biotherapeutic candidates.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Lead and execute comparability and forced degradation studies, including study design, sample preparation, data analysis, and reporting
Lead and perform enrichment, fractionation, and characterization of protein variants (e.g., charge and size variants) using techniques such as SEC, CE-SDS, IEX, and MS
Develop, optimize, and document analytical/characterization methods for biotherapeutic candidates, including drafting protocols/reports and establishing system suitability/acceptance criteria

Qualification

Separation scienceLiquid chromatographyBasic laboratory skillsData analysisPublic speakingPresentation design

Required

Master's and Doctoral students studying Biochemistry, Chemistry or Analytical Chemistry, Chemical Engineering, Molecular Biology, Pharmaceutical Science, Bioengineering/Biotechnology, or a related discipline
Candidates must have an expected graduation date after August 2026
Basic laboratory skills such as pipetting and dilution required
US Work Authorization is required at time of application
Ability to report onsite to New Haven, CT site 4-5 days per week. This role will not provide relocation assistance

Preferred

Knowledge and understanding of separation science, including liquid chromatography (Size-Exclusion Chromatography, Ion-Exchange Chromatography)/Capillary Isoelectric Focusing/Imaged Capillary Electrophoresis is preferred
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design

Company

Alexion Pharmaceuticals, Inc.

company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin
Company data provided by crunchbase